Loading the player...

3:12 MD /Alert Exclusive

NEXT UP
Breast Cancer Survivors Report Cognitive Impairment After PPI Use

Breaking Study Finds Optimal Screening Interval for Breast Cancer

Despite breast cancer being one of the most common cancers among women in the United States, there are still questions about when and how often women should be screened. A recent study showed that annual mammograms have more benefits than a longer duration between screenings.

Next Up In Breast Cancer

Adding Tucatinib to Trastuzumab and Capecitabine Improves HER2-positive Breast Cancer Survival

Adding Tucatinib to Trastuzumab and Capecitabine Improves HER2-positive Breast Cancer Survival

Understanding Recent Breast Cancer Vaccine Breakthroughs

Understanding Recent Breast Cancer Vaccine Breakthroughs

Preventing Breast Cancer in Women Carrying BRCA1 Gene

Preventing Breast Cancer in Women Carrying BRCA1 Gene

FDA Approves New HER2+ Breast Cancer Therapy

FDA Approves New HER2+ Breast Cancer Therapy

Going the Distance With Metastatic Breast Cancer: 'Personal Best'

Going the Distance With Metastatic Breast Cancer: "Personal Best"

Why Dual Light Therapy Hits Triple Negative Breast Cancer Harder

Why Dual Light Therapy Hits Triple Negative Breast Cancer Harder

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

Genetic Testing May Influence Breast Cancer Treatment that Goes Against Practice Guidelines

Genetic Testing May Influence Breast Cancer Treatment that Goes Against Practice Guidelines

New Study Questions Need for Immediate Treatment for All Breast Cancer

New Study Questions Need for Immediate Treatment for All Breast Cancer

New Uses for Existing Therapies in Breast Cancer Research

New Uses for Existing Therapies in Breast Cancer Research

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

Breaking Study Finds Optimal Screening Interval for Breast Cancer

Breaking Study Finds Optimal Screening Interval for Breast Cancer

Breast Cancer Survivors Report Cognitive Impairment After PPI Use

Breast Cancer Survivors Report Cognitive Impairment After PPI Use

Combining Eribulin and Pembrolizumab in Metastatic Triple-Negative Breast Cancer

Combining Eribulin and Pembrolizumab in Metastatic Triple-Negative Breast Cancer

Adding Capecitabine to TDM-1 Demonstrates No Benefit in Breast Cancer Patients

Adding Capecitabine to TDM-1 Demonstrates No Benefit in Breast Cancer Patients

RNA TROJAN Promotes Triple-Negative Breast Cancer Progression

RNA TROJAN Promotes Triple-Negative Breast Cancer Progression

Biosimilar Trastuzumab-dttb Launched for Treatment of HER2+ Breast Cancer

Biosimilar Trastuzumab-dttb Launched for Treatment of HER2+ Breast Cancer

Improving Outcomes for Early Onset Breast Cancer

Improving Outcomes for Early Onset Breast Cancer

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

Genomic Profiling Improves Metastatic Breast Cancer Research

Genomic Profiling Improves Metastatic Breast Cancer Research

Various Breast Cancer Research Challenges in Recurrence, Triple Negative BC

Various Breast Cancer Research Challenges in Recurrence, Triple Negative BC

European Breast Cancer Guidelines Highlight Difficulties in Minimizing Risk

European Breast Cancer Guidelines Highlight Difficulties in Minimizing Risk

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

FDA Approves New Treatment for HER2-Positive Breast Cancer

FDA Approves New Treatment for HER2-Positive Breast Cancer

Study Shows Tolerable Safety of Abemaciclib Plus Pembrolizumab in HER2-, Metastatic Breast Cancer

Study Shows Tolerable Safety of Abemaciclib Plus Pembrolizumab in HER2-, Metastatic Breast Cancer

Study of Immunotherapy Combinations for Patients with Metastatic Breast Cancer

Study of Immunotherapy Combinations for Patients with Metastatic Breast Cancer

Metastatic Breast Cancer: 'The Journey Begins'

Metastatic Breast Cancer: "The Journey Begins"

FDA Approves First Antibody-Drug Conjugate for TNBC

FDA Approves First Antibody-Drug Conjugate for TNBC

Oncologist Explains How Gammapod Works for Breast Cancer

Oncologist Explains How Gammapod Works for Breast Cancer

New Breast Cancer Therapy Shows Significant Response

New Breast Cancer Therapy Shows Significant Response

Advancing Breast Cancer Care With Gammapod Radiation

Advancing Breast Cancer Care With Gammapod Radiation

Early Study Results show Abemaciclib Reduces Risk of Recurrence in HR+ HER2- Breast Cancer

Early Study Results show Abemaciclib Reduces Risk of Recurrence in HR+ HER2- Breast Cancer

Immunotherapy/Chemo Combo Improves PFS in Metastatic Triple-Negative Breast Cancer

Immunotherapy/Chemo Combo Improves PFS in Metastatic Triple-Negative Breast Cancer

Dietary Supplement Use May Affect Recurrence, Mortality After Breast Cancer Treatment

Dietary Supplement Use May Affect Recurrence, Mortality After Breast Cancer Treatment

TNBC: Phase 3 ASCENT Study Halts Due to “Compelling Efficacy”

TNBC: Phase 3 ASCENT Study Halts Due to “Compelling Efficacy”

MD /Alert Exclusives

Adding Capecitabine to TDM-1 Demonstrates No Benefit in Breast Cancer Patients

Adding Capecitabine to TDM-1 Demonstrates No Benefit in Breast Cancer Patients

Early Study Results show Abemaciclib Reduces Risk of Recurrence in HR+ HER2- Breast Cancer

Early Study Results show Abemaciclib Reduces Risk of Recurrence in HR+ HER2- Breast Cancer

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

Breast Cancer Survivors Report Cognitive Impairment After PPI Use

Breast Cancer Survivors Report Cognitive Impairment After PPI Use

Biosimilar Trastuzumab-dttb Launched for Treatment of HER2+ Breast Cancer

Biosimilar Trastuzumab-dttb Launched for Treatment of HER2+ Breast Cancer

FDA Approves First Antibody-Drug Conjugate for TNBC

FDA Approves First Antibody-Drug Conjugate for TNBC

TNBC: Phase 3 ASCENT Study Halts Due to “Compelling Efficacy”

TNBC: Phase 3 ASCENT Study Halts Due to “Compelling Efficacy”

Genetic Testing May Influence Breast Cancer Treatment that Goes Against Practice Guidelines

Genetic Testing May Influence Breast Cancer Treatment that Goes Against Practice Guidelines

New Study Questions Need for Immediate Treatment for All Breast Cancer

New Study Questions Need for Immediate Treatment for All Breast Cancer

FDA Approves New HER2+ Breast Cancer Therapy

FDA Approves New HER2+ Breast Cancer Therapy

Immunotherapy/Chemo Combo Improves PFS in Metastatic Triple-Negative Breast Cancer

Immunotherapy/Chemo Combo Improves PFS in Metastatic Triple-Negative Breast Cancer

Dietary Supplement Use May Affect Recurrence, Mortality After Breast Cancer Treatment

Dietary Supplement Use May Affect Recurrence, Mortality After Breast Cancer Treatment

Adding Tucatinib to Trastuzumab and Capecitabine Improves HER2-positive Breast Cancer Survival

Adding Tucatinib to Trastuzumab and Capecitabine Improves HER2-positive Breast Cancer Survival

European Breast Cancer Guidelines Highlight Difficulties in Minimizing Risk

European Breast Cancer Guidelines Highlight Difficulties in Minimizing Risk

FDA Approves New Treatment for HER2-Positive Breast Cancer

FDA Approves New Treatment for HER2-Positive Breast Cancer

Breaking Study Finds Optimal Screening Interval for Breast Cancer

Breaking Study Finds Optimal Screening Interval for Breast Cancer

FDA Warns of Cancer Risk After Mastectomy, Reconstruction

FDA Warns of Cancer Risk After Mastectomy, Reconstruction

New Breast Cancer Therapy Shows Significant Response

New Breast Cancer Therapy Shows Significant Response

ASCO 2020 Annual Meeting

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

MINDACT Study Shows Continued Success in Determining Chemotherapy Usage

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

Pembrolizumab + Chemotherapy Beneficial in Triple-Negative Breast Cancer

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

Advanced ER+ HER2+ Breast Cancer Combo Therapy Fails to Improve Outcomes

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

HER2CLIMB Study Shows Benefits of Triple Therapy for HER2+ Metastatic Breast Cancer with Brain Metastases

Study Shows Tolerable Safety of Abemaciclib Plus Pembrolizumab in HER2-, Metastatic Breast Cancer

Study Shows Tolerable Safety of Abemaciclib Plus Pembrolizumab in HER2-, Metastatic Breast Cancer

Combining Eribulin and Pembrolizumab in Metastatic Triple-Negative Breast Cancer

Combining Eribulin and Pembrolizumab in Metastatic Triple-Negative Breast Cancer

Featured Breast Cancer Videos

Going the Distance With Metastatic Breast Cancer: 'Personal Best'

Going the Distance With Metastatic Breast Cancer: "Personal Best"

Metastatic Breast Cancer: 'The Journey Begins'

Metastatic Breast Cancer: "The Journey Begins"

Breaking Research

Personalized Assay Surpasses Limits for Detecting Tumor DNA in Breast Cancer Patients

Personalized Assay Surpasses Limits for Detecting Tumor DNA in Breast Cancer Patients

Overcoming Treatment Resistance in Breast Cancer

Overcoming Treatment Resistance in Breast Cancer

Oncologist Explains How Gammapod Works for Breast Cancer

Oncologist Explains How Gammapod Works for Breast Cancer

Advancing Breast Cancer Care With Gammapod Radiation

Advancing Breast Cancer Care With Gammapod Radiation

RNA TROJAN Promotes Triple-Negative Breast Cancer Progression

RNA TROJAN Promotes Triple-Negative Breast Cancer Progression

Preventing Breast Cancer in Women Carrying BRCA1 Gene

Preventing Breast Cancer in Women Carrying BRCA1 Gene

Curated For You

Genomic Profiling Improves Metastatic Breast Cancer Research

Genomic Profiling Improves Metastatic Breast Cancer Research

New Uses for Existing Therapies in Breast Cancer Research

New Uses for Existing Therapies in Breast Cancer Research

Various Breast Cancer Research Challenges in Recurrence, Triple Negative BC

Various Breast Cancer Research Challenges in Recurrence, Triple Negative BC

Understanding Recent Breast Cancer Vaccine Breakthroughs

Understanding Recent Breast Cancer Vaccine Breakthroughs

Study of Immunotherapy Combinations for Patients with Metastatic Breast Cancer

Study of Immunotherapy Combinations for Patients with Metastatic Breast Cancer

Why Dual Light Therapy Hits Triple Negative Breast Cancer Harder

Why Dual Light Therapy Hits Triple Negative Breast Cancer Harder

Improving Outcomes for Early Onset Breast Cancer

Improving Outcomes for Early Onset Breast Cancer